Advertisement
YOU ARE HERE: LAT HomeCollectionsDeath

Business Briefing / DRUGS

Rituxan user dies of brain infection

September 12, 2008|From Times Wire Services

Federal regulators said one case of a deadly brain infection has been reported in a patient taking Genentech Inc. and Biogen Idec Inc.'s popular arthritis and cancer drug Rituxan.

The Food and Drug Administration said the woman died of the rare viral infection more than a year and a half after discontinuing the drug, which Genentech and Biogen Idec co-market in the U.S.

The FDA said the case was the first reported in a patient taking the drug for arthritis.

Advertisement
Los Angeles Times Articles
|
|
|